Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Oryctolagus cuniculus | Acyl-CoA:cholesterol acyltransferase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K00637 sterol O-acyltransferase [EC2.3.1.26], putative | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus granulosus | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus multilocularis | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma mansoni | sterol O-acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Neospora caninum | sterol O-acyltransferase, putative | Acyl-CoA:cholesterol acyltransferase | 305 aa | 258 aa | 20.2 % |
Dictyostelium discoideum | diacylglycerol O-acyltransferase 1 | Acyl-CoA:cholesterol acyltransferase | 305 aa | 278 aa | 21.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Treponema pallidum | ATP-dependent RNA helicase | 0.0147 | 0.4373 | 0.5 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0147 | 0.4373 | 0.4025 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.014 | 0.4052 | 0.3685 |
Schistosoma mansoni | sterol O-acyltransferase 1 | 0.0264 | 1 | 1 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0147 | 0.4373 | 1 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0147 | 0.4373 | 0.5 |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.0233 | 0.8525 | 0.8298 |
Trypanosoma cruzi | prolyl endopeptidase | 0.014 | 0.4052 | 0.9267 |
Loa Loa (eye worm) | hypothetical protein | 0.0238 | 0.8762 | 0.8572 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0056 | 0 | 0.5 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0147 | 0.4373 | 1 |
Echinococcus multilocularis | sterol O acyltransferase 1 | 0.0264 | 1 | 1 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.0151 | 0.459 | 1 |
Echinococcus granulosus | integrin alpha 3 | 0.0116 | 0.2894 | 0.2455 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0147 | 0.4373 | 1 |
Schistosoma mansoni | integrin alpha | 0.0151 | 0.459 | 0.4256 |
Loa Loa (eye worm) | hypothetical protein | 0.014 | 0.4052 | 0.3137 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0147 | 0.4373 | 1 |
Trypanosoma brucei | prolyl endopeptidase | 0.014 | 0.4052 | 0.9267 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0147 | 0.4373 | 1 |
Mycobacterium tuberculosis | Probable protease II PtrBa [first part] (oligopeptidase B) | 0.0125 | 0.3346 | 0.7653 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0147 | 0.4373 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0264 | 1 | 1 |
Echinococcus multilocularis | prolyl endopeptidase | 0.014 | 0.4052 | 0.3685 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0147 | 0.4373 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0147 | 0.4373 | 0.5 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0147 | 0.4373 | 0.4025 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0147 | 0.4373 | 0.4025 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0147 | 0.4373 | 0.4025 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.4373 | 0.3507 |
Loa Loa (eye worm) | hypothetical protein | 0.0114 | 0.282 | 0.1716 |
Plasmodium vivax | RNA helicase-1, putative | 0.0147 | 0.4373 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0147 | 0.4373 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0147 | 0.4373 | 1 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0147 | 0.4373 | 0.5 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.014 | 0.4052 | 0.3685 |
Mycobacterium ulcerans | protease II (oligopeptidase B), PtrB | 0.0056 | 0 | 0.5 |
Echinococcus multilocularis | integrin alpha 3 | 0.0116 | 0.2894 | 0.2455 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0147 | 0.4373 | 1 |
Leishmania major | prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative | 0.014 | 0.4052 | 0.9267 |
Loa Loa (eye worm) | hypothetical protein | 0.0119 | 0.3029 | 0.1957 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0147 | 0.4373 | 0.4025 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0147 | 0.4373 | 0.4025 |
Echinococcus granulosus | prolyl endopeptidase | 0.014 | 0.4052 | 0.3685 |
Brugia malayi | eukaryotic initiation factor 4A | 0.0147 | 0.4373 | 0.8771 |
Brugia malayi | prolyl oligopeptidase family protein | 0.014 | 0.4052 | 0.6959 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0147 | 0.4373 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Change (functional) | = -45 % | Percent change in total cholesterol (TC) in cholic acid (0.3%) -cholesterol (1.5%) -peanut oil(5.5%) -fed rats. | ChEMBL. | 1578488 |
IC50 (binding) | = 0.015 uM | In vitro inhibition of acyl coenzyme A:cholesterol acyltransferase, in intestinal microsomes isolated from cholesterol-fed rabbits | ChEMBL. | 1578488 |
IC50 (binding) | = 0.015 uM | In vitro inhibition of acyl coenzyme A:cholesterol acyltransferase, in intestinal microsomes isolated from cholesterol-fed rabbits | ChEMBL. | 1578488 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.